Matsushita S - Search Results

1

Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.

Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Matsushita S, Machida N, Nakagawa T, Lee VM, Trojanowski JQ, Sasaki H. Arai H, et al. Among authors: matsushita s. J Am Geriatr Soc. 1997 Oct;45(10):1228-31. doi: 10.1111/j.1532-5415.1997.tb03775.x. J Am Geriatr Soc. 1997. PMID: 9329486

2

Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases.

Itabashi S, Arai H, Matsui T, Matsushita S, Muramatsu T, Higuchi S, Trojanowski JQ, Sasaki H. Itabashi S, et al. Among authors: matsushita s. Exp Neurol. 1998 Jun;151(2):237-40. doi: 10.1006/exnr.1998.6802. Exp Neurol. 1998. PMID: 9628759 Free article.

3

Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.

Morikawa Y, Arai H, Matsushita S, Kato M, Higuchi S, Miura M, Kawakami H, Higuchi M, Okamura N, Tashiro M, Matsui T, Sasaki H. Morikawa Y, et al. Among authors: matsushita s. Alcohol Clin Exp Res. 1999 Apr;23(4):575-7. Alcohol Clin Exp Res. 1999. PMID: 10235290

4

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.

Maruyama M, Arai H, Sugita M, Tanji H, Higuchi M, Okamura N, Matsui T, Higuchi S, Matsushita S, Yoshida H, Sasaki H. Maruyama M, et al. Among authors: matsushita s. Exp Neurol. 2001 Dec;172(2):433-6. doi: 10.1006/exnr.2001.7814. Exp Neurol. 2001. PMID: 11716567

5

Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease.

Muramatsu T, Matsushita S, Arai H, Sasaki H, Higuchi S. Muramatsu T, et al. Among authors: matsushita s. J Neural Transm (Vienna). 1996;103(10):1205-10. doi: 10.1007/BF01271205. J Neural Transm (Vienna). 1996. PMID: 9013407

6

Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.

Matsushita S, Arai H, Muramatsu T, Makimoto K, Nakagawa T, Sasaki H, Higuchi S. Matsushita S, et al. Exp Neurol. 1997 Aug;146(2):567-9. doi: 10.1006/exnr.1997.6558. Exp Neurol. 1997. PMID: 9270069

7

Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease.

Higuchi M, Arai H, Nakagawa T, Higuchi S, Muramatsu T, Matsushita S, Kosaka Y, Itoh M, Sasaki H. Higuchi M, et al. Among authors: matsushita s. Neuroreport. 1997 Aug 18;8(12):2639-43. doi: 10.1097/00001756-199708180-00001. Neuroreport. 1997. PMID: 9295092

8

[Diagnosing the mild cognitive impairment stage of Alzheimer's disease].

Maruyama M, Matsui T, Tanji H, Ootsuki M, Nemoto M, Tomita N, Okamura N, Matsushita S, Higuchi S, Kodama M, Arai H, Sasaki H. Maruyama M, et al. Among authors: matsushita s. Seishin Shinkeigaku Zasshi. 2004;106(3):269-80. Seishin Shinkeigaku Zasshi. 2004. PMID: 15164576 Review. Japanese.

9

Plasma homocysteine and risk of coexisting silent brain infarction in Alzheimer's disease.

Matsui T, Nemoto M, Maruyama M, Yuzuriha T, Yao H, Tanji H, Ootsuki M, Tomita N, Matsushita S, Higuchi S, Yoshida Y, Seki T, Iwasaki K, Furukawa K, Arai H. Matsui T, et al. Among authors: matsushita s. Neurodegener Dis. 2005;2(6):299-304. doi: 10.1159/000092316. Neurodegener Dis. 2005. PMID: 16909012

10

A transient increase in cerebrospinal fluid tau level after epileptic seizure in an elderly patient.

Matsui T, Maruyama M, Matsushita S, Arai H, Higuchi S, Maruyama K. Matsui T, et al. Among authors: matsushita s. J Am Geriatr Soc. 2007 Dec;55(12):2096-7. doi: 10.1111/j.1532-5415.2007.01440.x. J Am Geriatr Soc. 2007. PMID: 18081683 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,291 results

Search Page

Filters